| |
Article Title |
Author(s) |
Pages |
|
|
|
Masthead
|
|
iv
|
|
|
|
Editorial Board
|
|
v
|
|
|
|
Contents
|
|
vi-vii
|
|
| News and Topics |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Prostate-specific antigen (PSA) should drive doing prostate biopsies
04 April 2011
In some respects, prostate-specific antigen (PSA) screening has fallen victim to its own success. From 1990–1991 to 2006, death rates from cancer in general have decreased by 21.0% among U.S. men . Ne...
|
Stacy Loeb,
William J. Catalona
|
1-2
|
|
| Review Article |
| |
Article Title |
Author(s) |
Pages |
|
|
|
The multi-disciplinary management of high-risk prostate cancer
30 November 2009
Abstract: Prostate cancer is the most frequently diagnosed cancer and the second most common cause of cancer death in men in the United States. Such men can experience a continuum of disease presentat...
|
Jonathan C. Picard,
Ali-Reza Golshayan,
David T. Marshall,
Krisha J. Opfermann,
Thomas E. Keane
et al.
|
3-15
|
|
| Original Articles |
| Clinical - Prostate |
| |
Article Title |
Author(s) |
Pages |
|
|
|
GREB1 tissue expression is associated with organ-confined prostate cancer
30 November 2009
Abstract: Objective: By reason of its heterogeneous behavior, it is difficult to determine the prognosis of many prostate cancer cases. Patients with the same clinicopathologic conditions may present ...
|
Alberto A. Antunes,
Kátia R. Leite,
Sabrina T. Reis,
Juliana M. Sousa-Canavez,
Luiz H. Camara-Lopes,
Marcos F. Dall'Oglio,
Miguel Srougi
et al.
|
16-20
|
|
|
|
Biopsy accuracy in identifying unilateral prostate cancer depends on prostate weight
07 January 2010
Abstract: Objective: To evaluate the association between prostate weight and the diagnostic performance of routine biopsy schemes in detecting unilateral prostate cancer (PCa) that may be amenable to ...
|
Matvey Tsivian,
Daniel M. Moreira,
Leon Sun,
Vladimir Mouraviev,
Masaki Kimura,
Judd W. Moul,
Thomas J. Polascik
et al.
|
21-25
|
|
|
|
Nerve-sparing robotic prostatectomy in preoperatively high-risk patients is safe and efficacious
02 March 2010
Abstract: Objective: Given the higher likelihood of extraprostatic extension in high-risk patients, many urologists will sacrifice the neurovascular bundles in such patients in an attempt to decrease ...
|
Hugh J. Lavery,
Fatima Nabizada-Pace,
John R. Carlucci,
Jonathan S. Brajtbord,
David B. Samadi
et al.
|
26-32
|
|
|
|
C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): Confirmatory results
08 March 2010
Abstract: We previously reported that higher serum concentrations of C-reactive protein (CRP) are associated with shorter survival in men with castration-resistant prostate cancer (CRPC). To confirm t...
|
Renee C. Prins,
Brooks L. Rademacher,
Solange Mongoue-Tchokote,
Joshi J. Alumkal,
Julie N. Graff,
Kristine M. Eilers,
Tomasz M. Beer
et al.
|
33-37
|
|
| Clinical - Bladder |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Orthotopic bladder substitution following radical cystectomy in women: Comparative study between sigmoid and ileal neobladders
07 January 2010
Abstract: The objective of this study was to retrospectively compare the clinical outcomes of sigmoid and ileal neobladders (NBs) created in women. This study included 18 and 14 women who underwent or...
|
Hideaki Miyake,
Junya Furukawa,
Mototsugu Muramaki,
Atsushi Takenaka,
Masato Fujisawa
et al.
|
38-43
|
|
|
|
The presence of circulating tumor cells does not predict extravesical disease in bladder cancer patients prior to radical cystectomy
14 December 2009
Abstract: Objective: Due to imprecise clinical staging, the finding of extravesical and node-positive disease at the time of radical cystectomy (RC) for patients with clinically localized bladder canc...
|
Thomas J. Guzzo,
Brian K. McNeil,
Trinity J. Bivalacqua,
Debra J. Elliott,
Lori J. Sokoll,
Mark P. Schoenberg
et al.
|
44-48
|
|
|
|
Subepithelial growth patterns in urothelial carcinoma—frequency and prognostic significance
08 March 2010
Abstract: Purpose: Most urothelial carcinomas are exophytic, but some tumors exhibit subepithelial components, either in the form of endophytic growth pattern (EGP) or as von Brunn's nests involvement...
|
Ofer N. Gofrit,
Amos Shapiro,
Dov Pode,
Ran Katz,
Vladimir Yutkin,
Kevin C. Zorn,
Galina Pizov
et al.
|
49-54
|
|
| Clinical - Testis |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Detection of inguinal lymph node involvement in penile squamous cell carcinoma by 18F-fluorodeoxyglucose PET/CT: A prospective single-center study
21 December 2009
Abstract: Background: The extent of lymph node involvement is the most relevant prognostic factor in patients with penile cancer. Objective: To prospectively analyze the diagnostic accuracy of 18F-FDG...
|
Boris Schlenker,
Bernhard Scher,
Reinhold Tiling,
Sabine Siegert,
Edwin Hungerhuber,
Christian Gratzke,
Derya Tilki,
Oliver Reich,
Peter Schneede,
Peter Bartenstein,
Christian G. Stief,
Michael Seitz
et al.
|
55-59
|
|
|
|
Primary vs. post-chemotherapy retroperitoneal lymph node dissection (RPLND) in patients with presence of teratoma at orchiectomy
02 March 2010
Abstract: Objective: The presence of teratoma in the primary orchiectomy specimen creates controversies for subsequent management. Although predominant teratoma is less likely to metastasize, teratoma...
|
Stephen B. Williams,
Ravi Kacker,
Graeme S. Steele,
Jerome P. Richie
|
60-63
|
|
| Laboratory |
| |
Article Title |
Author(s) |
Pages |
|
|
|
The orthotopic Fischer/AY-27 rat bladder urothelial cell carcinoma model to test the efficacy of different apaziquone formulations
30 November 2009
Abstract: Objectives: Apaziquone used intravesically showed significant activity in phase I and II marker lesion studies in non-muscle-invasive bladder cancer. The objective of this study was to asses...
|
Harm C. Arentsen,
Kees Hendricksen,
Christina A. Hulsbergen-van de Kaa,
Guru Reddy,
Egbert Oosterwijk,
J. Alfred Witjes
et al.
|
64-68
|
|
|
|
Rictor-dependent AKT activation and inhibition of urothelial carcinoma by rapamycin
08 March 2010
Abstract: Objective: We previously reported a very high cumulative incidence of urothelial carcinoma in Taiwanese kidney transplant recipients. Rapamycin, the inhibitor of mTOR Complex 1, provides alt...
|
Ming-Ju Wu,
Chi-Hao Chang,
Yung-Tsung Chiu,
Mei-Chin Wen,
Kuo-Hsiung Shu,
Jian-Ri Li,
Kun-Yuan Chiu,
Yen-Ta Chen
et al.
|
69-77
|
|
| Seminar Section Introduction |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Impact of poverty and race/ethnicity on treatment and management of urologic cancers
29 November 2011
Poverty and race/ethnicity have long been factors associated with disparities in access to care, severity of disease at diagnosis, receipt of treatment, and outcomes of care. It is important to unders...
|
Katherine S. Virgo,
Stacey A. Fedewa
|
78-80
|
|
| Seminar Articles |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Disparities in bladder cancer
29 November 2011
Abstract: Among men, bladder cancer is the fourth most common malignancy and ninth leading cause of death from cancer in the United States. In contrast, it is the 11th most common malignancy and 12th ...
|
Bruce L. Jacobs,
Jeffrey S. Montgomery,
Yun Zhang,
Ted A. Skolarus,
Alon Z. Weizer,
Brent K. Hollenbeck
et al.
|
81-88
|
|
|
|
The role of socioeconomic status in renal cell carcinoma
12 September 2011
Abstract: Gender, race, income level, and socioeconomic status (SES) are factors in the decision to diagnose and treat patients with localized and advanced renal cell carcinoma (RCC). These variables ...
|
Nicholas J. Hellenthal,
Carlos E. Bermejo
|
89-94
|
|
|
|
Testicular cancer: A narrative review of the role of socioeconomic position from risk to survivorship
29 November 2011
Abstract: Background: Testicular cancer (TC) is one of the most curable cancers. Given survival rates of close to 100% with appropriate therapy, ensuring proper treatment is essential. We reviewed and...
|
Lisa C. Richardson,
Antonio J. Neri,
Eric Tai,
Jeffrey D. Glenn
|
95-101
|
|
|
|
Prostate cancer survivorship: Lessons from caring for the uninsured
29 November 2011
Abstract: Since 2001, UCLA has operated IMPACT: Improving Access, Counseling, and Treatment for Californians with Prostate Cancer (CaP). Funded by the California Department of Public Health, with a cu...
|
Karim Chamie,
Sarah E. Connor,
Sally L. Maliski,
Arlene Fink,
Lorna Kwan,
Mark S. Litwin
et al.
|
102-108
|
|
|
|
Survey Section Editorial Board
|
|
109
|
|
| Urologic Oncology Survey |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Commentary on “Partial orchiectomy for presumed malignancy in patients with a solitary testis due to a prior germ cell tumor: A large North American experience.” Lawrentschuk N, Zuniga A, Grabowksi AC, Rendon RA, Jewett MA, Division of Urology, Department of Surgical Oncology, Princess Margaret Hospital and the University Health Network, University of Toronto, Toronto, Ontario, Canada: J Urol 2011;185:508–13
Partial orchiectomy is becoming more accepted for indications such as a metachronous germ cell tumor due to reported oncological control, and minimal functional, physical, and psychological morbidity....
|
Jerome P. Richie
|
110
|
|
|
|
Commentary on “Survival after resection for metastatic testicular nonseminomatous germ cell cancer to the lung or mediastinum.” Kenneth A. Kesler,a Laura E. Kruter,a Susan M. Perkins,b Karen M. Rieger,a Katherine J. Sullivan,a Matthew L. Runyan,a John W. Brown,a Lawrence H. Einhorn,c aDepartment of Surgery, Cardiothoracic Division and Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana; bDepartment of Biostatistics, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana; cHematology-Oncology Divisions, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana: Ann Thorac Surg 2011;91:1085–93
Since the advent of cisplatin-based chemotherapy, nonseminomatous germ cell tumors (NSGCT) have been considered one of the most curable solid neoplasms and a model for multimodality cancer therapy. We...
|
Jerome P. Richie
|
110-111
|
|
|
|
Commentary on “Screening for testicular cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement.” Collaborators (18), U.S. Preventive Services Task Force: Ann Intern Med 2011 Apr 5;154:483–6
Reaffirmation of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for testicular cancer.
|
Jerome P. Richie
|
111
|
|
|
|
Commentary on “Successful treatment of post-chemotherapy azoospermia with microsurgical testicular sperm extraction: The Weill Cornell experience.” Hsiao W, Stahl PJ, Osterberg EC, Nejat E, Palermo GD, Rosenwaks Z, Schlegel PN, Weill Cornell Medical College, James Buchanan Brady Foundation, New York, New York: J Clin Oncol 2011;29:1607–11
Advances in chemotherapy have led to greater longevity and paternity may be an important consideration for post-chemotherapy survivors of childhood cancers. While traditionally considered sterile, men...
|
Jerome P. Richie
|
112
|
|
|
|
Commentary on “Adverse prognostic factors for testicular cancer-specific survival: A population-based study of 27,948 patients.” Fosså SD, Cvancarova M, Chen L, Allan AL, Oldenburg J, Peterson DR, Travis LB, Oslo University Hospital, University of Oslo, Norway: J Clin Oncol 2011;29:963–70
The prognostic significance of age at testicular cancer (TC) diagnosis, socioeconomic status (SES), race, and marital status on TC-specific mortality is not well-characterized. In a cancer that is so ...
|
Jerome P. Richie
|
112-113
|
|
|
|
Commentary on “Management of rectal injury during robotic radical prostatectomy.” Kheterpal E, Bhandari A, Siddiqui S, Pokala N, Peabody J, Menon M, Vattikuti Urology Institute, Henry Ford Health System, Henry Ford Hospital, Detroit, Michigan: Urology 2011;77:976–9
To review the incidence and management of rectal injury in 4,400 consecutive cases of robotic radical prostatectomy at a single institution.
|
Christopher Kane
|
113
|
|
|
|
Commentary on “Posterior reconstruction before vesicourethral anastomosis in patients undergoing robot-assisted laparoscopic prostatectomy leads to earlier return to baseline continence.” Brien JC, Barone B, Fabrizio M, Given R, Department of Urology, Eastern Virginia Medical School, Norfolk, Virginia: J Endourol 2011;25:441–5
Reapproximation of Denonvilliers' fascia adjacent to bladder neck to the rectourethralis, or posterior reconstruction (PR), has been suggested to improve continence in post-prostatectomy patients. We ...
|
Christopher Kane
|
114
|
|
|
|
Commentary on “Posterior rhabdosphincter reconstruction during robotic assisted radical prostatectomy: Results from a phase II randomized clinical trial.” Sutherland DE, Linder B, Guzman AM, Hong M, Frazier HA II, Engel JD, Bianco FJ Jr., Department of Urology, George Washington University, Washington, DC: J Urol 2011;185:1262–7
Posterior rhabdosphincter reconstruction following radical prostatectomy was designed to improve early urinary continence. We executed a randomized clinical trial to test this conjecture in men underg...
|
Christopher Kane
|
114-115
|
|
|
|
Commentary on “Outcomes of robotic partial nephrectomy for renal masses with nephrometry score of ≥7.” White MA, Haber GP, Autorino R, Khanna R, Hernandez AV, Forest S, Yang B, Altunrende F, Stein RJ, Kaouk JH, Department of Surgery, Center for Laparoscopic and Robotic Surgery, Glickman Urological and Kidney Institute, Cleveland, Ohio: Urology 2011;77:809–13
To evaluate the safety and feasibility of robotic partial nephrectomy for patients with complex renal masses.
|
Christopher Kane
|
115-116
|
|
|
|
Commentary on “Surgery-related complications of robot-assisted radical cystectomy with intracorporeal urinary diversion.” Schumacher MC, Jonsson MN, Hosseini A, Nyberg T, Poulakis V, Pardalidis NP, John H, Wiklund PN, Department of Molecular Medicine and Surgery, Division of Urology, Karolinska Institutet, Stockholm, Sweden: Urology 2011;77:871–6
To assess the surgery-related complications at robot-assisted radical cystectomy with total intracorporeal urinary diversion during our learning curve in treating 45 patients with bladder cancer.
|
Christopher Kane
|
116
|
|
| News and Topics |
| |
Article Title |
Author(s) |
Pages |
|
|
|
The Society of Urologic Oncology's reply to the US Preventative Services Task Force's recommendation on PSA testing
The United States Preventative Services Task Force (USPSTF) recently published its preliminary recommendation against PSA testing. There have been a variety of highly vocal critics and supporters of t...
|
Edward M. Messing,
Peter Albertsen,
Gerald L. Andriole,
Peter R. Carroll,
Eric A. Klein
et al.
|
117-119
|
|
|
|
Information for Authors
|
|
120
|
|
